GeneDx Holdings Corp. Operating Income
GeneDx Holdings Corp. (WGS) reported Operating Income of -$17.45 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-03
- GeneDx Holdings Corp. operating income (loss) for the quarter ending 2026-06-30 was -$17.45M, a 294.81% decline year-over-year.
- GeneDx Holdings Corp. operating income (loss) for the quarter ending 2026-03-31 was -$57.47M.
- GeneDx Holdings Corp. operating income (loss) for the quarter ending 2025-12-31 was -$14.23M, a 261.65% decline year-over-year.
- GeneDx Holdings Corp. operating income (loss) for the quarter ending 2025-09-30 was -$3.25M.
- GeneDx Holdings Corp. operating income (loss) for fiscal 2025 was -$13.08M.
- GeneDx Holdings Corp. operating income (loss) for fiscal 2024 was -$23.21M.
- GeneDx Holdings Corp. operating income (loss) for fiscal 2023 was -$180.60M.
- GeneDx Holdings Corp. operating income (loss) for fiscal 2022 was -$667.65M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$17.45M 10-Q · filed 2026-08-03 | -$74.93M 10-Q · filed 2026-08-03 | -$89.16M derived: sum of 3 quarters · filed 2026-08-03 | -$92.41M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2026-03-31 | -$57.47M 10-Q · filed 2026-05-04 | -$71.71M derived: sum of 2 quarters · filed 2026-05-04 | -$74.96M derived: sum of 3 quarters · filed 2026-05-04 | -$66.00M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-12-31 | -$14.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$17.49M derived: sum of 2 quarters · filed 2026-02-23 | -$8.53M derived: sum of 3 quarters · filed 2026-08-03 | -$13.08M 10-K · filed 2026-02-23 | |||
| 2025-09-30 | -$3.25M 10-Q · filed 2025-10-28 | $5.71M derived: sum of 2 quarters · filed 2026-08-03 | $1.16M 10-Q · filed 2025-10-28 | $9.96M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-06-30 | $8.96M 10-Q · filed 2026-08-03 | $4.41M 10-Q · filed 2026-08-03 | $13.21M derived: sum of 3 quarters · filed 2026-08-03 | $5.43M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-03-31 | -$4.55M 10-Q · filed 2026-05-04 | $4.25M derived: sum of 2 quarters · filed 2026-05-04 | -$3.52M derived: sum of 3 quarters · filed 2026-05-04 | -$14.10M derived: sum of 4 quarters · filed 2026-05-04 | |||
| 2024-12-31 | $8.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.03M derived: sum of 2 quarters · filed 2026-02-23 | -$9.55M derived: sum of 3 quarters · filed 2026-02-23 | -$23.21M 10-K · filed 2026-02-23 | |||
| 2024-09-30 | -$7.78M 10-Q · filed 2025-10-28 | -$18.36M derived: sum of 2 quarters · filed 2025-10-28 | -$32.02M 10-Q · filed 2025-10-28 | -$57.66M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2024-06-30 | -$10.58M 10-Q · filed 2025-07-29 | -$24.24M 10-Q · filed 2025-07-29 | -$49.88M derived: sum of 3 quarters · filed 2026-02-23 | -$92.85M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2024-03-31 | -$13.66M 10-Q · filed 2025-04-30 | -$39.30M derived: sum of 2 quarters · filed 2026-02-23 | -$82.27M derived: sum of 3 quarters · filed 2026-02-23 | -$133.89M derived: sum of 4 quarters · filed 2026-02-23 | |||
| 2023-12-31 | -$25.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$68.61M derived: sum of 2 quarters · filed 2026-02-23 | -$120.23M derived: sum of 3 quarters · filed 2026-02-23 | -$180.60M 10-K · filed 2026-02-23 | |||
| 2023-09-30 | -$42.97M 10-Q · filed 2024-10-29 | -$94.59M derived: sum of 2 quarters · filed 2024-10-29 | -$154.95M 10-Q · filed 2024-10-29 | -$479.83M derived: sum of 4 quarters · filed 2024-10-29 | |||
| 2023-06-30 | -$51.62M 10-Q · filed 2024-07-30 | -$111.99M 10-Q · filed 2024-07-30 | -$436.87M derived: sum of 3 quarters · filed 2024-07-30 | -$527.68M derived: sum of 4 quarters · filed 2024-07-30 | |||
| 2023-03-31 | -$60.36M 10-Q · filed 2024-04-29 | -$385.25M derived: sum of 2 quarters · filed 2024-04-29 | -$476.06M derived: sum of 3 quarters · filed 2024-04-29 | -$638.71M derived: sum of 4 quarters · filed 2024-04-29 | |||
| 2022-12-31 | -$324.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$415.70M derived: sum of 2 quarters · filed 2024-02-23 | -$578.35M derived: sum of 3 quarters · filed 2024-02-23 | -$667.65M 10-K · filed 2024-02-23 | |||
| 2022-09-30 | -$90.82M 10-Q · filed 2023-11-03 | -$253.47M derived: sum of 2 quarters · filed 2023-11-03 | -$342.77M 10-Q · filed 2023-11-03 | -$458.55M derived: sum of 4 quarters · filed 2023-11-03 | |||
| 2022-06-30 | -$162.65M 10-Q · filed 2023-08-08 | -$251.95M 10-Q · filed 2023-08-08 | -$367.73M derived: sum of 3 quarters · filed 2023-08-08 | -$456.00M derived: sum of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | -$89.31M 10-Q · filed 2023-05-09 | -$205.09M derived: sum of 2 quarters · filed 2023-05-09 | -$293.35M derived: sum of 3 quarters · filed 2023-05-09 | -$338.80M derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | -$115.78M 10-K · filed 2022-03-14 | -$204.04M derived: sum of 2 quarters · filed 2022-11-14 | -$249.49M derived: sum of 3 quarters · filed 2022-11-14 | -$446.15M 10-K · filed 2023-03-16 | |||
| 2021-09-30 | -$88.26M 10-Q · filed 2022-11-14 | -$89.60M 10-Q · filed 2021-11-15 | -$133.71M derived: sum of 2 quarters · filed 2022-11-14 | -$330.37M 10-Q · filed 2022-11-14 | -$330.13M 10-Q · filed 2021-11-15 | -$455.41M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$45.45M 10-Q · filed 2022-08-15 | -$1.28M 10-Q · filed 2021-07-21 | -$242.10M 10-Q · filed 2022-08-15 | -$3.12M 10-Q · filed 2021-07-21 | -$367.15M derived: sum of 3 quarters · filed 2022-08-15 | -$423.17M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | -$196.66M 10-Q · filed 2022-05-12 | -$1.85M 10-Q · filed 2021-05-24 | -$321.70M derived: sum of 2 quarters · filed 2022-05-12 | -$377.72M derived: sum of 3 quarters · filed 2022-05-12 | -$411.88M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$125.05M 10-K · filed 2022-03-14 | -$206.19K 10-K/A · filed 2021-05-05 | -$215.22M derived: sum of 3 quarters · filed 2022-03-14 | -$241.99M 10-K · filed 2023-03-16 | |||
| 2020-09-30 | -$59.71K 10-Q · filed 2020-11-16 | -$90.18M derived: sum of 2 quarters · filed 2022-03-14 | -$116.95M 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | -$34.16M 10-K · filed 2022-03-14 | -$60.93M derived: sum of 2 quarters · filed 2022-03-14 | |||||
| 2020-03-31 | -$26.77M 10-K · filed 2022-03-14 | ||||||
| 2019-12-31 | -$30.41M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |